The University of Wisconsin–Madison and Immuto Scientific have teamed up to explore new therapeutic targets in colorectal cancer. According to the University of Wisconsin School of Medicine and Public Health, this collaboration aims to use Immuto’s AI-enabled platform to discover novel treatments for solid colorectal cancer tumors.
Dr. Dustin Deming, a professor of medicine at the University of Wisconsin School of Medicine and Public Health, leads the project. “Our collection of patient-derived colorectal cancer organoids enables exploration of tumor biology and therapeutic vulnerabilities in ways that traditional models cannot,” said Deming.